# The Pharmacokinetic Interaction Between Celecoxib and Rebamipide

> **NCT01549743** · PHASE1 · COMPLETED · sponsor: **Hanlim Pharm. Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Rebamipide
- **DRUG:** Celecoxib plus Rebamipide

## Key facts

- **NCT ID:** NCT01549743
- **Lead sponsor:** Hanlim Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-09
- **Primary completion:** 2012-06-13
- **Final completion:** 2012-06-13
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549743, "The Pharmacokinetic Interaction Between Celecoxib and Rebamipide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01549743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*